Loading
Life sciences · Journal article
Pharmaceuticals · September 25, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Background/Objectives: Cancer remains a major cause of mortality worldwide, and resistance to therapy continues to limit treatment success. Improving the susceptibility of cancer cells to immune-mediated killing, particularly by natural killer (NK) cells, may enhance therapeutic outcomes. This study aimed to determine whether natural products can sensitize non-small cell lung cancer (NSCLC) cells to NK cell-mediated cytotoxicity. Methods: The cytotoxic effects of natural products on NCI-H1975 cells were assessed using a cell viability assay. NK cell-mediated killing was evaluated in a co-culture system. The expression of MICA/B, Fas, and TRAIL receptors (DR4 and DR5) was analyzed by flow cytometry. Results: Treatment with a natural product and NK cells significantly enhanced cancer cell toxicity compared with either treatment alone. Mechanistically, KS markedly increased the expression of TRAIL death receptors on NCI-H1975 cells. Treatment with KS at 62.5 μg/mL increased the proportion of DR4-positive cells from 13.4% to 56.7% and DR5-positive cells from 99.0% to 99.9%. Conclusions: These findings indicate that natural products can increase the susceptibility of cancer cells to NK cell-mediated killing by upregulating TRAIL receptor expression and promoting apoptosis. This sensitizing effect may provide a useful strategy to improve the efficacy of cancer immunotherapy.